Prof. Dr. med. Hans Christian Günter Korting

Curriculum Vitae
Date: May 2008

Name: Korting Hans Christian Günter, Prof. Dr. med.
Marital status: Married, 2 children
Affiliation: Klinik und Poliklinik für Dermatologie und Allergologie
Klinikum der Ludwig-Maximilians-Universität
Frauenlobstraße 9-11
D-80337 München
Telephone: 0049 - 89-5160-6154
Private address: Im Dol 54
D-14195 Berlin
Telephone: 0049 - 30-83226340
Date and location of birth: March 21, 1952; Tübingen
Current positions:
Executive Academic Director
at the Department of Dermatology and Allergology of the University of Munich,
Lieutenant Colonel in the Medical Forces in a
NATO-Staff in Heidelberg
Doctoral Thesis: Dr. med., 26/01/77
Medical Speciality: Dermatologist, 14/12/85
Additional Medial Title: Allergologist, 24/01/85
Field and date of Ph. D.:

Dermatology and Venereology, 04/12/85
Publications covered by the
ISI Web of Knowledge®:
Frequency of citations:


3.717 times cited

Selection of frequently
cited publications:
Korting H.C., Ollert M., Georgii A., Fröschl M., In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol. 1988;26:2626-31 (143x)

Ollert M.W., Söhnchen R., Korting H.C., Ollert U., Bräutigam S., Bräutigam W., Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun. 1993;61:4560-8 (70x)

Ollert M.W., Wende C., Görlich M., McMullan-Vogel C.G., Borg-von Zepelin M., Vogel C.W., Korting H.C., Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol. 1995;33:2543-9 (62x)

Schaller M., Schafer W., Korting H.C., Hube B., Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol. 1998;29:605-15 (104x)

Korting H.C., Schaller M., Eder G., Hamm G., Böhmer U., Hube B., Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother. 1999;43:2038-42 (58x)

Schaller M., Korting H.C., Schafer W., Bastert J., Chen W., Hube B., Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol. 1999;34:169-80 (85x)

Manggau, Kim DS, Ruwisch L, Vogler R, Korting HC, Schäfer-Korting M, Kleuser B: 1 Alpha,25-dihydroxyvitamin D-3 protects human keratinocytes f apoptosis formation of sphingosine-1-phosphate. J Invest Dermatol 2001; 117: 1241-1249 (34x)

Korting HC, Unholzer A, Schäfer-Korting M, Tausch I, Gassmueller J, Nietsch KH: Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol Appl Skin Physiol 2002;15:85-91 (16x)

Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M: Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002; 10:489-95 (12x)

Roeder A, Kirschning CJ, Schaller M, Weindl G, Wagner H, Korting HC, Rupec RA: Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via Toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans. J Infect Dis 2004;190:1318-26 (12x)

Book publications: 16
Selection of relevant books:
Korting, H.C.; Sterry, W. (Hrsg.): Diagnostische Verfahren in der Dermatologie (Blackwell, Berlin, 1997)

Korting, H.C.; Schäfer-Korting, M. (Eds.): The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs (CRC Press, Boca Raton, 1998)

Korting, H.C.; Sterry, W. (Hrsg.): Therapeutische Verfahren in der Dermatologie. Dermatika und Kosmetika. (Blackwell, Berlin, 2001)

Korting HC, Callies R, Reusch M, Schlaeger M, Sterry W (Hrsg.): Dermatologische Qualitätssicherung. Leitlinien und Empfehlungen. (abw-Wissenschaftsverlag, Berlin, 5. Auflage 2007)

Editor of scientific journals: mycoses
Co-Editor of scientific journals (selection):

International Journal of Antimicrobial Agents;
American Journal of Clinical Dermatology,
Journal der Deutschen Dermatologischen Gesellschaft,
Skin Pharmacology and Physiology
Scientific focus: Dermatologic MicrobiologyiImmunology and dermatopharmacology, in particular molecular mycology of mucocutaneous candidoses (host parasite-interaction);

development of innovative pharmceutical ingredients (among others sphingosine-1-phosphate, plasmin) and carrier systems (liposomes, nanostructured lipidic carriers), in particular for skin diseases
Important prizes: Paul Gerson-Unna-Preis 1990 der Deutschen Dermatologischen Gesellschaft,
Forschungs-Förderungspreis 1994 der Deutschsprachigen Mykologischen Gesellschaft,
Heinz-P.R.-Seeliger-Preis 2000
Important obligations in scientific societies: Treasurer of Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) - Umbrella organization of 153 scientific medical societies in Germany;
Vice chairman of Society for Dermopharmacy (GD);
Secretary of Deutschsprachige Mykologische Gesellschaft (DMykG);
Member of the board of Deutsche STD-Gesellschaft (DSTDG);
Head of the Committee of Quality Assurance of Deutsche Dermatologische Gesellschaft (DDG)

Copyright © 2000- 2008 Institute for Dermopharmacy GmbH